Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to …

AC Correia, AR Monteiro, R Silva, JN Moreira… - Advanced Drug Delivery …, 2022 - Elsevier
The main limitation to the success of central nervous system (CNS) therapies lies in the
difficulty for drugs to cross the blood–brain barrier (BBB) and reach the brain. Regarding its …

Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release

A Gordillo-Galeano, CE Mora-Huertas - European Journal of Pharmaceutics …, 2018 - Elsevier
Colloidal systems based on lipids have attracted attention during the last two decades as a
delivery method of drugs that are poorly soluble in water. The investigations carried out have …

Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier

VR Salvi, P Pawar - Journal of Drug Delivery Science and Technology, 2019 - Elsevier
Lipid nanocarriers are developed as an alternative to polymeric nanoparticles, liposomes
and emulsions. Further, Nanostructured Lipid Nanocarriers are the second generation lipid …

Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies

M Geszke-Moritz, M Moritz - Materials Science and Engineering: C, 2016 - Elsevier
This work briefly reviews up-to-date developments in solid lipid nanoparticles (SLNs) as
effective nanocolloidal system for drug delivery. It summarizes SLNs in terms of their …

[HTML][HTML] Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells

MCO da Rocha, PB da Silva, MA Radicchi… - Journal of …, 2020 - Springer
Background Metastasis causes the most breast cancer-related deaths in women. Here, we
investigated the antitumor effect of solid lipid nanoparticles (SLN-DTX) when used in the …

[HTML][HTML] Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours

J Garg, K Pathania, SP Sah, SV Pawar - Future Journal of Pharmaceutical …, 2022 - Springer
Background In recent years, the field of nanotechnology and nanomedicine has transformed
the pharmaceutical industry with the development of novel drug delivery systems that …

[HTML][HTML] Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration

VN Thuy, TV Van, AH Dao, BJ Lee - OpenNano, 2022 - Elsevier
Enteral administration is the most convenient route despite the gastrointestinal physiological
barriers. Nanostructured lipid carriers (NLCs) have emerged as a promising strategy for …

[HTML][HTML] Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as food-grade nanovehicles for hydrophobic nutraceuticals or bioactives

CH Tang, HL Chen, JR Dong - Applied Sciences, 2023 - mdpi.com
Although solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have
been successfully used as drug delivery systems for about 30 years, the usage of these …

Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability

S Talegaonkar, A Bhattacharyya - Aaps Pharmscitech, 2019 - Springer
Lipid-based drug delivery systems has become a popular choice for oral delivery of
lipophilic drugs with dissolution rate limited oral absorption. Lipids are known to enhance …

Nanostructured lipid carriers: versatile oral delivery vehicle

N Poonia, R Kharb, V Lather, D Pandita - Future science OA, 2016 - Future Science
Oral delivery is the most accepted and economical route for drug administration and leads to
substantial reduction in dosing frequency. However, this route still remains a challenge for …